Search Tag: cardiovascular disease

Cardiology Management

#ESCCongress: Cardiovascular Medicine Will Never Be The Same

2019 29 Aug

ESC Congress is the world’s largest gathering of cardiovascular professionals contributing to global awareness of the latest clinical trials and breakthrough discoveries. ESC Congress 2019 together with the World Congress of Cardiology takes place from 31 August to 4 September at the Expo Porte de Versailles in Paris, France. The  ESC Congress... Read more

Health Management

Volume 19 - Issue 4, 2019

2019 26 Aug

Change content default value Read more

Executive Health Management

The Future of Cardiovascular Disease Treatment and Management

2019 26 Aug

Arthur M. Feldman, MD, PhD, Laura H. Carnell Professor of Medicine at the Lewis Katz School of Medicine at Temple University, has been recognised with the 2019 Distinguished Scientist Award-Basic Domain by the American College of Cardiology. Prof. Feldman has received this honour due to his contribution towards improving cardiovascular health and... Read more

Executive Health Management

Cardiology and mHealth – Rethink About Monitoring

2019 26 Aug

Summary: Overview about the value of mHealth in cardiology exemplified by some promising tools that for sure will change the way cardiology is practiced, especially in the management of rhythm disturbances like atrial fibrillation.   Where Are We Now?   Nowadays, there is a lot of hype about the role of wearables and mobile health (mHealth)... Read more

Executive Health Management

Sex & Gender Impacts in Cardiovascular Disease: A “Typical” Presentation of Cardiovascular Disease?

2019 26 Aug

Summary: Differences in sex and gender may account for gaps in treatment and prevention of cardiovascular disease, but at the same time, it also gives the opportunity for personalised sex and gender-specific medicine.   Typical presentations in medicine are defined in ways that health care professionals can draw on past experiences and education... Read more

Executive Health Management

Cardiovascular Disease Prevention 2019: Quo Vadis?

2019 26 Aug

Summary: Cardiovascular disease prevention strategies in 2019 remain a major healthcare issue, requiring an individualised approach for diagnostic and therapeutic decision making.   Introduction   Since investigators from the Framingham Heart Study first confirmed the existence and importance of cardiovascular disease (CVD) risk factors in... Read more

Executive Health Management

Nuclear Cardiology: Molecular Insights into the Heart

2019 26 Aug

Summary: Nuclear cardiology is a promising field located between research, imaging, and patient care. Through close interdisciplinary cooperation, a variety of cardiovascular diseases (eg coronary artery, inflammatory and infiltrative cardiac diseases) can not only be investigated, but also efficiently treated in daily clinical routine.    What... Read more

Executive Health Management

Hypertension – Prevention is Better Than Cure

2019 26 Aug

How can we get the most common, costly, and modifiable cardiovascular risk factor under control?     Cardiovascular disease (CVD) is the number one cause of death with an upward trend beyond 30% and a tripling in costs between 2010 and 2030, placing a significant economic burden on public healthcare services. 1,2,3 The most common risk factor... Read more

Cardiology Management

Ideal Cardiovascular Health Metrics and Major Cardiovascular Events

2019 01 Aug

The prevalence of Type 2 diabetes has become a public health issue, as the International Diabetes Federation recorded a total of 425 million adults between the ages of 20 and 79 that had diabetes in 2017. The main cause of disability and mortality in this cohort is due to issues involving cardiovascular health. The American Heart Association has now... Read more

Cardiology Management

Aspirin Efficacy - All in the Genes?

2019 25 Jul

The benefits of low-dosages of aspirin (75-100mg daily) for the secondary prevention of cardiovascular diseases (CVDs) exceed the risk of bleeding. However, most are still unclear whether aspirin has the same effects on primary prevention.   The recent results from three trials ASPREE, ASCEND and ARRIVE each tested the effects of 100mg of aspirin... Read more